These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 3091563)

  • 1. The carrier state: Neisseria meningitidis.
    Broome CV
    J Antimicrob Chemother; 1986 Jul; 18 Suppl A():25-34. PubMed ID: 3091563
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of sulfadiazine in the prophylaxis of group A meningococcal carriers in Egypt.
    Hassan A; Girgis N; Sippel J; Sorensen K; Yassin M
    Trop Geogr Med; 1974 Mar; 26(1):87-90. PubMed ID: 4208558
    [No Abstract]   [Full Text] [Related]  

  • 3. Meningococcal disease and its control.
    Riley HD
    South Med J; 1973 Jan; 66(1):107-14. PubMed ID: 4630520
    [No Abstract]   [Full Text] [Related]  

  • 4. Meningococcal meningitis following rifampin prophylaxis.
    Khuri-Bulos N
    Am J Dis Child; 1973 Nov; 126(5):689-91. PubMed ID: 4200808
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of Neisseria meningitidis group A polysaccharide vaccine on nasopharyngeal carrier rates.
    Sivonen A
    J Infect; 1981 Sep; 3(3):266-72. PubMed ID: 6821094
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention in bacterial meningitis].
    Spanjaard L; Bol P
    Ned Tijdschr Geneeskd; 1990 Mar; 134(12):575-7. PubMed ID: 2320157
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylaxis for meningococcal disease.
    Artenstein MS
    JAMA; 1975 Mar; 231(10):1035-7. PubMed ID: 803581
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemoprophylaxis for Neisseria meningitidis in an isolated Arctic community.
    Nicolle LE; Postl B; Kotelewetz E; Remillard F; Bourgault AM; Albritton W; Harding GK; Ronald A
    J Infect Dis; 1982 Jan; 145(1):103-9. PubMed ID: 6798128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence markers in patient and carrier strains of Neisseria meningitidis.
    Holten E; Frøholm LO; Gaustad P
    Scand J Infect Dis; 1984; 16(3):267-70. PubMed ID: 6436964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasopharyngeal carriage of Neisseria meningitidis in general population and meningococcal disease.
    Ichhpujani RL; Mohan R; Grover SS; Joshi PR; Kumari S
    J Commun Dis; 1990 Dec; 22(4):264-8. PubMed ID: 2129123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meningococcal meningitis in Spain (1978-1981). III. Susceptibility of the meningococcal strains isolated from patients and carriers to the main agents used in the treatment and chemoprophylaxis of meningococcal infections].
    Sáez Nieto JA; Vázquez J; Casal J
    Rev Sanid Hig Publica (Madr); 1983; 57(5-6):587-602. PubMed ID: 6422536
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the effect of Rifampin on the nasopharyngeal carriage of Neisseria meningitidis. A preliminary report.
    Beam WE; Newberg NR; Devine LF
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):316-20. PubMed ID: 4996195
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of rifampicin on meningococcal carriage in family contacts in northern Nigeria.
    Blakebrough IS; Gilles HM
    J Infect; 1980 Jun; 2(2):137-43. PubMed ID: 6821084
    [No Abstract]   [Full Text] [Related]  

  • 14. Meningococcal infection in Egypt: laboratory findings in meningitis patients and the prevalence of pharyngeal infection in patients and contacts.
    Sippel JE; Girgis NI
    Am J Trop Med Hyg; 1978 Sep; 27(5):980-5. PubMed ID: 102212
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifampin and minocycline in meningococcal disease.
    Beaty HN
    Rev Infect Dis; 1983; 5 Suppl 3():S451-8. PubMed ID: 6415780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfadiazine-resistant group A Neisseria meningitidis.
    Alexander CE; Sanborn WR; Cherriere G; Crocker WH; Ewald PE; Kay CR
    Science; 1968 Sep; 161(3845):1019. PubMed ID: 4970371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulphadiazine-resistant group A meningococci isolated during the 1968 meningitis epidemic in Greece.
    Vassiliadis P; Kanellakis A; Papadakis J
    J Hyg (Lond); 1969 Jun; 67(2):279-88. PubMed ID: 4978421
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of rifampin on the nasopharyngeal carriage of Neisseria meningitidis in a military population.
    Beam WE; Newberg NR; Devine LF; Pierce WE; Davies JA
    J Infect Dis; 1971 Jul; 124(1):39-46. PubMed ID: 5004115
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of rifampicin in healthy carriers of "N. meningitidis" (author's transl)].
    Delia S; Mauro A; Miceli MT
    Ann Sclavo; 1978; 20(5):675-80. PubMed ID: 111629
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifampin. Levels in serum and saliva and effect on the meningococcal carrier state.
    Devine LF; Johnson DP; Hagerman CR; Pierce WE; Rhode SL; Peckinpaugh RO
    JAMA; 1970 Nov; 214(6):1055-9. PubMed ID: 4990906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.